CryoPort, Inc. (CYRX)
Stock Price Chart
Key Info
| Market Cap | 1.72B |
| Revenue (ttm) | 37.99M |
| Net Income (ttm) | -23.16M |
| Shares Out | 38.78M |
| EPS (ttm) | -0.63 |
| PE Ratio | n/a |
| Forward PE | 138.89 |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 26, 2020 |
| Last Price | $44.42 |
| Previous Close | $43.98 |
| Change ($) | 0.44 |
| Change (%) | 1.00% |
| Day's Open | 43.58 |
| Day's Range | 43.54 - 45.20 |
| Day's Volume | 74,753 |
| 52-Week Range | 13.01 - 60.82 |
More Stats
| Market Cap | 1.72B |
| Enterprise Value | 1.52B |
| Earnings Date (est) | Nov 5, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 38.78M |
| Float | 31.25M |
| EPS (basic) | -0.62 |
| EPS (diluted) | -0.63 |
| FCF / Share | -0.15 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 6.77M |
| Short Ratio | 7.48 |
| Short % of Float | 21.65% |
| Beta | 1.31 |
| PE Ratio | n/a |
| Forward PE | 138.89 |
| P/FCF Ratio | n/a |
| PS Ratio | 45.35 |
| PB Ratio | 13.34 |
| Revenue | 37.99M |
| Operating Income | -22.66M |
| Net Income | -23.16M |
| Free Cash Flow | -5.68M |
| Net Cash | 202.36M |
| Net Cash / Share | 5.22 |
| Gross Margin | 45.68% |
| Operating Margin | -59.65% |
| Profit Margin | -61.00% |
| FCF Margin | -14.96% |
| ROA | -7.25% |
| ROE | -19.68% |
| ROIC | -20.90% |
Analyst Summary
Analyst Consensus: Buy
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 33.94 | 19.63 | 11.95 | 7.68 | 3.94 | 2.66 | 1.10 | 0.56 | 0.48 | 0.12 |
| Revenue Growth | 72.94% | 64.18% | 55.68% | 95.13% | 47.95% | 141.69% | 98.07% | 16.85% | 303.12% | - |
| Gross Profit | 17.35 | 10.24 | 5.97 | 3.10 | 1.17 | 0.44 | -0.49 | -0.84 | -0.83 | -0.60 |
| Operating Income | -17.68 | -8.64 | -7.89 | -8.77 | -5.59 | -5.08 | -6.32 | -7.43 | -5.60 | -4.20 |
| Net Income | -18.33 | -9.56 | -7.90 | -13.11 | -7.03 | -19.57 | -6.38 | -7.83 | -6.15 | -5.65 |
| Shares Outstanding | 33.39 | 28.21 | 22.96 | 14.22 | 5.01 | 4.07 | 3.15 | 2.41 | 1.11 | 0.42 |
| Earnings Per Share | -0.55 | -0.34 | -0.34 | -0.93 | -2.44 | -4.81 | -2.04 | -3.24 | -5.52 | -13.56 |
| Operating Cash Flow | -1.32 | -3.35 | -3.58 | -5.72 | -4.13 | -4.38 | -4.79 | -6.78 | -4.81 | -2.85 |
| Capital Expenditures | -5.34 | -2.91 | -1.71 | -1.06 | -0.07 | -0.14 | -0.16 | -0.26 | -0.34 | -0.03 |
| Free Cash Flow | -6.66 | -6.27 | -5.30 | -6.78 | -4.20 | -4.52 | -4.94 | -7.04 | -5.15 | -2.89 |
| Cash & Equivalents | 94.73 | 47.61 | 15.41 | 4.89 | 1.41 | 0.37 | 0.56 | 4.87 | 9.37 | 3.72 |
| Total Debt | 4.80 | 14.77 | - | 0.65 | 1.54 | 2.98 | 2.72 | 1.81 | 4.02 | 4.22 |
| Net Cash / Debt | 89.93 | 32.84 | 15.41 | 4.24 | -0.13 | -2.61 | -2.16 | 3.06 | 5.35 | -0.50 |
| Assets | 136 | 56.62 | 20.26 | 8.11 | 2.61 | 1.71 | 1.76 | 6.21 | 11.03 | 4.78 |
| Liabilities | 9.59 | 18.07 | 2.38 | 2.43 | 3.02 | 4.01 | 3.82 | 2.48 | 5.08 | 5.69 |
| Book Value | 126 | 38.55 | 17.89 | 5.68 | -0.42 | -2.30 | -2.06 | 3.73 | 5.95 | -0.91 |
Company Profile
Company Details
| Full Name | CryoPort, Inc. |
| Country | United States |
| Employees | 105 |
| CEO | Jerrell W. Shelton |
Stock Information
| Ticker Symbol | CYRX |
| Stock Exchange | NASDAQ |
| Sector | Industrials |
| Industry | Integrated Freight & Logistics |
| Unique Identifier | NASDAQ: CYRX |
Description
Cryoport provides temperature-controlled logistics and biostorage services to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Global Logistics Solutions and Global Bioservices. The Global Logistics Solutions segment offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures. This segment also provides Cryoport Express Advanced Therapy Shippers, which offer verification information and supply chain support for biopharma companies; and Cryoport Express C3 Shippers, a non-cryogenic temperature-controlled shipper designed to maintain a controlled temperature. In addition, it offers Cryoport Express SmartPak II Condition Monitoring System to track the key aspects and condition of each shipment; and Cryoport Express Analytics to track the time-based metrics for order processing time and on-time deliveries, as well as profiling shipping lanes to determine average transit times and predicting shipping exceptions based on historical metric. The Global Bioservices segment provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens. The company also offers logistics support and management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.